Grant
Research Grant for Rett Syndrome
Published by International Rett Syndrome Foundation
GrantRett SyndromeIRSF believes that research into a variety of Rett and Rett-related topics is necessary to create treatments and eventual cures for every individual living with Rett syndrome. We proudly invest in such research at every stage: from basic science that can change the way we think about MeCP2 to clinical research that directly impacts potential treatments. We also help connect Rett researchers with external funding opportunities.
View this resource Bookmark this resource
Towards a Concrete Improvement in the Quality of Life of Patients with Autoimmune Myasthenia
Published by FONDATION MALADIES RARES
Autoimmune MyastheniaThe Fondation Maladies Rares and UCB have joined forces to offer a €30, 000 research grant to a humanities and social sciences (HSS) research project focused on findingconcrete, short-term ways ofimproving the life course of patients suffering from generalized autoimmune myasthenia gravis.
The grant will be awarded to a research project focusing on the individual, family and/or social consequences specifically linked to generalized autoimmune myasthenia gravis, in order to gain a better understanding of the impact of this disease, and in particular muscular fatigability, on quality of life at the level of the individual, couple or family, for example.
View this resource Bookmark this resourceThe Fondation Maladies Rares is pleased to announce the launch of its “GenOmics” 2024 call for projects.
The aim of this AAP is to support hypothesis-driven research projects aimed at exploring the genetic and molecular basis of rare diseases using NGS approaches (WES, WGS, RNA-seq, small RNA-seq, ChIP-seq, Methyl-seq, etc.).
Support from the Fondation Maladies Rares will give project leaders access to innovative high-throughput sequencing technologies for the analysis of exomes, genomes, transcriptomes or epigenomes.
View this resource Bookmark this resourceFunding is key when it comes to developing an idea or research result. Every year, KTH Innovation helps KTH projects secure over 40 million SEK in funding.
View this resource Bookmark this resourceThe Chan Zuckerberg Initiative invites applications for five-year projects from patient-led rare disease advocacy organizations to join the Rare As One Network. Grantee organizations will accelerate research within individual disease areas and work across specified areas of scientific focus (channelopathies; ciliopathies; or inborn errors of metabolism) to develop shared research priorities and proposals.
View this resource Bookmark this resourceIn addition to traditional grantmaking to support people and organizations working toward our missions in Science, Education, and within our communities, the Chan Zuckerberg Initiative makes venture investments in impact-focused companies, builds tools and products that we can scale and give away for free, and supports capacity building to achieve progress across our work.
View this resource Bookmark this resource
Sanofi iAwards Europe
Published by SANOFI
Cell and Gene TherapiesImmunologyInflammatory DiseasesOncologyRare and Neurological DiseasesA booster to transform groundbreaking ideas in the field of target identification, disease knowledge and translational science into innovative therapeutic solutions. We partner with best-in-class academics to serve a common goal: accelerating innovation for patients.
View this resource Bookmark this resourceThis scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding that could improve human life, health and wellbeing.
View this resource Bookmark this resource